Immunotherapy of neuromyelitis optica

Benjamin Bienia, Roumen Balabanov*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Neuromyelitis optica (NMO) is a chronic inflammatory disease of the central nervous system that affects the optic nerves and spinal cord resulting in visual impairment and myelopathy. There is a growing body of evidence that immunotherapeutic agents targeting T and B cell functions, as well as active elimination of proinflammatory molecules from the peripheral blood circulation, can attenuate disease progression. In this review, we discuss the immunotherapeutic options and the treatment strategies in NMO. We also analyze the pathogenic mechanisms of the disease in order to provide recommendations regarding treatments.

Original languageEnglish (US)
Article number741490
JournalAutoimmune Diseases
StatePublished - 2013

ASJC Scopus subject areas

  • Immunology and Microbiology (miscellaneous)
  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Immunotherapy of neuromyelitis optica'. Together they form a unique fingerprint.

Cite this